First patient dosed in Molecular and Orano Med’s MP0712 trial
Initial data is anticipated in 2026, with comprehensive safety and efficacy findings projected for 2027.
Initial data is anticipated in 2026, with comprehensive safety and efficacy findings projected for 2027.
Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Clinical trial experts cite trust and regulatory uncertainty as AI barriers
Kidney disease risk higher after Covid infection than after influenza infection
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
Oncology trial systems debut at SCOPE 2026 as AI adoption accelerates